NY Times: Disgraced Theranos CEO Elizabeth Holmes suddenly seems really nice and down to Earth.
A reporter fell for it. We won’t.
Related Articles
Scoop: “Randomized controlled trials are not always necessary,” new FDA vaccine chief Dr. Vinay Prasad says to staff.
Introductory comments yesterday reflected a return to nuance from a figure who had become contentious in recent years.
Scoop: “Randomized controlled trials are not always necessary,” new FDA vaccine chief Dr. Vinay Prasad says to staff.
Introductory comments yesterday reflected a return to nuance from a figure who had become contentious in recent years.
This week in public hell—umm, health.
But also a couple of good news updates, just to keep you sane.
The First 100 Days: Health, Medicine, and Science Under Attack…From Within.
A rundown on DOGE versus public health and science, and the Trump administration’s dangerous plans to squander assets that keep us safe, and to surrender…
Inside the FDA: Inheriting turmoil, new commissioner addresses morale, faces important tests, and says there will be no reorganization at the agency.
Weeks into his tenure, FDA Commissioner Dr. Marty Makary addresses turbulence described by current and former officials, asserts his independence, and holds hopes for a…
Exclusive: In conversation with FDA Commissioner Dr. Marty Makary.
In our wide-ranging Q&A, Dr. Makary outlines his vision, addresses low morale, asserts his independence, explains his stance on Novavax, and says “no” to an…
Exclusive: In conversation with FDA Commissioner Dr. Marty Makary.
In our wide-ranging Q&A, Dr. Makary outlines his vision, addresses low morale, asserts his independence, explains his stance on Novavax, and says “no” to an…
This week in the Trump administration’s “adventures” in public health.
From uncertain vaccine recommendations to defunding oversight of group homes for the disabled—and some sudden policy reversals in the face of pushback—it was a busy…
Sunday Read: What that leaked HHS reorganization document actually is—and what to expect next.
What’s a “passback,” and how likely are these changes to occur? A former Acting Director of the CDC and other experts offer insights.
New: A 64-page HHS restructuring proposal outlines sweeping cuts to US public health. Here it is, in its entirety.
Inside Medicine is made possible entirely by reader upgrades.